Par Drugs & Chemicals Ltd is primarily engaged in manufacturing of Active Pharma Ingredients (APIs) and fine chemicals for domestic & international markets.
Financial Results:
Par Drugs & Chemicals Ltd reported Revenues for Q1FY24 of ₹22.93 Crores down from ₹23.51 Crore year on year, a fall of 2.47%.
Total Expenses for Q1FY24 of ₹19.64 Crores down from ₹20.59 Crores year on year, a fall of 4.61%.
Consolidated Net Profit of ₹2.47 Crores up 7.86% from ₹2.29 Crores in the same quarter of the previous year.
The Earnings per Share is ₹2.01, up 8.06% from ₹1.86 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.